CYP1A1 and breast cancer: The mechanism of interaction between AhR and CYP1A1 or CYP2, where both are involved in the metabolism of estrogen which may lead to alteration in steroid levels modulating bioactivation of therapeutic agents and xenobiotics and elevating the risk of breast cancer in smoking women.